COMMUNIQUÉS West-GlobeNewswire

-
Psychedelic Science 2025 Conference Announces Workshops, Holiday Sale, and Scholarship Deadline
05/12/2024 -
How Hypauer Helps Clinics Scale, Grow, and Reach More Patients
05/12/2024 -
IHA Recognizes California Provider Organizations for Healthcare Performance
05/12/2024 -
PHAXIAM Therapeutics : monthly information related to total number of voting rights and shares composing the share capital – November 29, 2024
05/12/2024 -
PHAXIAM Therapeutics : information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 29 novembre 2024
05/12/2024 -
Acentra Health’s Independent Medical Review Division Earns Accreditation from Leading Care Quality and Safety Organization
05/12/2024 -
New generation steps up to continue IBA’s entrepreneurial ownership
05/12/2024 -
La nouvelle génération s’engage pour perpétuer l’ancrage entrepreneurial d’IBA
05/12/2024 -
Wugen to Present Clinical Data at the 2024 ASH Annual Meeting Ahead of Pivotal Trial Launch of Off-the-Shelf, Allogeneic, CD7-Targeted CAR-T Cell Therapy WU-CART-007
05/12/2024 -
Coloplast A/S - Decisions at the Annual General Meeting 2024
05/12/2024 -
Dr. Ryan Saadi Commends Individuals Who Dedicate Time to Public Service, and Congratulates Mayor Victor Sordillo on His Induction Into the NJ League of Municipalities Hall of Fame
05/12/2024 -
Unlock the Secrets to Healthy Aging: BioAro Unveils $199 Epigenetic Test at UAE Longevity Fitness Challenge
05/12/2024 -
HD Nursing to Showcase Advances in Fall Risk Prediction at IHI Forum 2024
05/12/2024 -
Sharps Technology’s CEO Issues Shareholder Letter Highlighting Hungary Manufacturing Facility Expansion Plans to Increase SecureGard and SoloGard Product Supply and Revenue
05/12/2024 -
Lungpacer Medical Announces Premarket Approval for AeroPace® System
05/12/2024 -
Aionics Unveils Expansion into Aviation Batteries Fueled by Strategic Investments and Industry Partnerships
05/12/2024 -
Vanqua Bio to Present Pre-Clinical Data on VQ-201, a Next Generation C5aR1 Antagonist for the Treatment of Inflammatory Disorders
05/12/2024 -
Qualigen Therapeutics Announces Regained Compliance with Nasdaq's Minimum Bid Price Requirement and the Equity Requirement
05/12/2024 -
Prenetics’ IM8 and University of Oxford Begin Groundbreaking Space Experiment to Study Accelerated Aging and Longevity on the ISS with SpaceX, Supported by Space Applications Services
05/12/2024
Pages